The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.
ICBI provides a platform to academic entrepreneurs for translation of their discoveries into commercial products for healthcare. ICBI will catalyze formation of new companies leading to significant economic and social impact.View all
Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai ...View all
Molecular Analysis Scientist- Output Traits Discovery R&D
Dow AgroSciences, based in Indianapolis, Indiana, USA, develops l...
28 June, 2013
Detail Oriented and Experienced Clinical Research Supply Manager
Detail Oriented and Experience Clinical Research Drug Supply Mana...
27 June, 2013